EIR Samsung Biologics May 2018

Diane Raccasi FDA, Michael Shanks FDA$595.00 - Available Now

FDA investigators audited the Samsung Biologics - Incheon, Korea (the Republic of) facility and issued inspectional observation (via FDA 483) on 11 May 2018.

Product details

  • Category:
  • Inspection end: 11 May 2018
  • Location: Incheon, Korea (the Republic of)
  • FEI: 3010479596
Add To Cart